SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-22-039845
Filing Date
2022-06-29
Accepted
2022-06-29 19:11:05
Documents
1
Period of Report
2022-06-20

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 2338
  Complete submission text file 0001209191-22-039845.txt   4004
Mailing Address 177 E COLORADO BLVD SUITE 700 PASADENA CA 91105
Business Address 177 E COLORADO BLVD SUITE 700 PASADENA CA 91105 626-696-4702
ARROWHEAD PHARMACEUTICALS, INC. (Issuer) CIK: 0000879407 (see all company filings)

IRS No.: 460408024 | State of Incorp.: DE | Fiscal Year End: 0930
SIC: 2834 Pharmaceutical Preparations

Mailing Address 177 E COLORADO BLVD SUITE 700 PASADENA CA 91105
Business Address
Oliver Tracie (Reporting) CIK: 0001935706 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38042 | Film No.: 221056079